Cargando…

Treatment Preferences in Patients With Early Glottic Cancer

OBJECTIVE: For early glottic carcinoma, the 2 main treatment modalities are radiotherapy (RT) and transoral CO(2) laser microsurgery (TLM). The aim of this study was to investigate treatment preferences and considerations in patients with early glottic carcinoma (T1-T2) who were given a choice betwe...

Descripción completa

Detalles Bibliográficos
Autores principales: van Loon, Yda, Hendriksma, Martine, Langeveld, Ton P.M., de Jong, Martin A., Baatenburg de Jong, Rob J., Sjögren, Elisabeth V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815424/
https://www.ncbi.nlm.nih.gov/pubmed/29291278
http://dx.doi.org/10.1177/0003489417749253
_version_ 1783300497067737088
author van Loon, Yda
Hendriksma, Martine
Langeveld, Ton P.M.
de Jong, Martin A.
Baatenburg de Jong, Rob J.
Sjögren, Elisabeth V.
author_facet van Loon, Yda
Hendriksma, Martine
Langeveld, Ton P.M.
de Jong, Martin A.
Baatenburg de Jong, Rob J.
Sjögren, Elisabeth V.
author_sort van Loon, Yda
collection PubMed
description OBJECTIVE: For early glottic carcinoma, the 2 main treatment modalities are radiotherapy (RT) and transoral CO(2) laser microsurgery (TLM). The aim of this study was to investigate treatment preferences and considerations in patients with early glottic carcinoma (T1-T2) who were given a choice between TLM and RT. SUBJECTS AND METHODS: Patients with early glottic cancer (suspected or confirmed extended T1 or limited T2) were counseled by an ENT-surgeon. A subset of 32 patients was also counseled by a radiotherapist. Treatment choice and considerations were recorded and analyzed. RESULTS: Of 175 patients, 168 patients (96%) chose TLM, and 7 patients (4%) chose RT. The most common reason for choosing TLM was shorter treatment and more treatment options in case of recurrence. Subanalysis showed that additional counseling by the radiotherapist did not seem to affect our patients’ preferences for TLM in this group. CONCLUSIONS: The majority of patients in our study prefer TLM to RT when given a choice. Reasons given indicate that optimizing future treatment options and practical considerations seemed more important to our patients than primary functional outcome. Further research is needed to study patient-related and physician-related factors to gain more insight into this complicated process of shared decision making.
format Online
Article
Text
id pubmed-5815424
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-58154242018-03-01 Treatment Preferences in Patients With Early Glottic Cancer van Loon, Yda Hendriksma, Martine Langeveld, Ton P.M. de Jong, Martin A. Baatenburg de Jong, Rob J. Sjögren, Elisabeth V. Ann Otol Rhinol Laryngol Articles OBJECTIVE: For early glottic carcinoma, the 2 main treatment modalities are radiotherapy (RT) and transoral CO(2) laser microsurgery (TLM). The aim of this study was to investigate treatment preferences and considerations in patients with early glottic carcinoma (T1-T2) who were given a choice between TLM and RT. SUBJECTS AND METHODS: Patients with early glottic cancer (suspected or confirmed extended T1 or limited T2) were counseled by an ENT-surgeon. A subset of 32 patients was also counseled by a radiotherapist. Treatment choice and considerations were recorded and analyzed. RESULTS: Of 175 patients, 168 patients (96%) chose TLM, and 7 patients (4%) chose RT. The most common reason for choosing TLM was shorter treatment and more treatment options in case of recurrence. Subanalysis showed that additional counseling by the radiotherapist did not seem to affect our patients’ preferences for TLM in this group. CONCLUSIONS: The majority of patients in our study prefer TLM to RT when given a choice. Reasons given indicate that optimizing future treatment options and practical considerations seemed more important to our patients than primary functional outcome. Further research is needed to study patient-related and physician-related factors to gain more insight into this complicated process of shared decision making. SAGE Publications 2017-12-31 2018-03 /pmc/articles/PMC5815424/ /pubmed/29291278 http://dx.doi.org/10.1177/0003489417749253 Text en © The Author(s) 2017 http://www.creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Articles
van Loon, Yda
Hendriksma, Martine
Langeveld, Ton P.M.
de Jong, Martin A.
Baatenburg de Jong, Rob J.
Sjögren, Elisabeth V.
Treatment Preferences in Patients With Early Glottic Cancer
title Treatment Preferences in Patients With Early Glottic Cancer
title_full Treatment Preferences in Patients With Early Glottic Cancer
title_fullStr Treatment Preferences in Patients With Early Glottic Cancer
title_full_unstemmed Treatment Preferences in Patients With Early Glottic Cancer
title_short Treatment Preferences in Patients With Early Glottic Cancer
title_sort treatment preferences in patients with early glottic cancer
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815424/
https://www.ncbi.nlm.nih.gov/pubmed/29291278
http://dx.doi.org/10.1177/0003489417749253
work_keys_str_mv AT vanloonyda treatmentpreferencesinpatientswithearlyglotticcancer
AT hendriksmamartine treatmentpreferencesinpatientswithearlyglotticcancer
AT langeveldtonpm treatmentpreferencesinpatientswithearlyglotticcancer
AT dejongmartina treatmentpreferencesinpatientswithearlyglotticcancer
AT baatenburgdejongrobj treatmentpreferencesinpatientswithearlyglotticcancer
AT sjogrenelisabethv treatmentpreferencesinpatientswithearlyglotticcancer